Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Analyzing Fatty Acid Profiles and Oxylipins in Adipose Tissue Depots of Obese Individuals
FY 2024-25
Summary
Chronic low-grade inflammation plays an important role in the development of type 2 diabetes mellitus (T2DM) and obesity. This inflammation often originates in the adipose tissue (AT), also known as fat tissue, and disrupts metabolic processes. Fatty acids (FA) are molecules in the body that can influence inflammation. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are known for their anti-inflammatory effects, they reduce the pro-inflammatory markers and support the production of compounds that resolve inflammation. However, the exact function of FAs, n-3 PUFAs and their derivatives (oxylipins) remains unclear in T2DM and their interactions with inflammation. Therefore, my research aims to explore the relationship between n-3 PUFAs, oxylipins, and inflammation in AT. I hypothesize that human AT from obese T2DM subjects will have lower detection levels of n-3 PUFAs and its associated oxylipins compared to obese non-T2DM subjects. I have received 30 visceral (VAT) and subcutaneous (SAT) AT samples from obese (BMI ≥ 30) non-T2DM and obese T2DM bariatric surgery donors. So far, I have worked on VAT samples to assess their FA profile. My next steps involve assessing FA profiles in SAT to assess for any depot specific differences and stratifying the data based on sex, fasting glucose, cholesterol, liver health status and medication history to draw connections with AT inflammation. This study can enhance our understanding of metabolic health by offering new insights on how FAs influence inflammation in T2DM and obesity.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529718
Name
Ziai Sabrina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Analyzing Fatty Acid Profiles and Oxylipins in Adipose Tissue Depots of Obese Individuals
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose Tissue; Fatty Acid Profiles; Inflammation; Obesity; Omega-3 Polyunsaturated Fatty Acid; Oxylipins; Type 2 Diabetes
Abstract
Chronic low-grade inflammation plays an important role in the development of type 2 diabetes mellitus (T2DM) and obesity. This inflammation often originates in the adipose tissue (AT), also known as fat tissue, and disrupts metabolic processes. Fatty acids (FA) are molecules in the body that can influence inflammation. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are known for their anti-inflammatory effects, they reduce the pro-inflammatory markers and support the production of compounds that resolve inflammation. However, the exact function of FAs, n-3 PUFAs and their derivatives (oxylipins) remains unclear in T2DM and their interactions with inflammation. Therefore, my research aims to explore the relationship between n-3 PUFAs, oxylipins, and inflammation in AT. I hypothesize that human AT from obese T2DM subjects will have lower detection levels of n-3 PUFAs and its associated oxylipins compared to obese non-T2DM subjects. I have received 30 visceral (VAT) and subcutaneous (SAT) AT samples from obese (BMI ≥ 30) non-T2DM and obese T2DM bariatric surgery donors. So far, I have worked on VAT samples to assess their FA profile. My next steps involve assessing FA profiles in SAT to assess for any depot specific differences and stratifying the data based on sex, fasting glucose, cholesterol, liver health status and medication history to draw connections with AT inflammation. This study can enhance our understanding of metabolic health by offering new insights on how FAs influence inflammation in T2DM and obesity.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ziai, Sabrina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~